JP2012523573A5 - - Google Patents

Download PDF

Info

Publication number
JP2012523573A5
JP2012523573A5 JP2012505086A JP2012505086A JP2012523573A5 JP 2012523573 A5 JP2012523573 A5 JP 2012523573A5 JP 2012505086 A JP2012505086 A JP 2012505086A JP 2012505086 A JP2012505086 A JP 2012505086A JP 2012523573 A5 JP2012523573 A5 JP 2012523573A5
Authority
JP
Japan
Prior art keywords
diagnostic method
disease
antibiotics
administration
induced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012505086A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012523573A (ja
JP5650718B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/002279 external-priority patent/WO2010118855A1/en
Publication of JP2012523573A publication Critical patent/JP2012523573A/ja
Publication of JP2012523573A5 publication Critical patent/JP2012523573A5/ja
Application granted granted Critical
Publication of JP5650718B2 publication Critical patent/JP5650718B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012505086A 2009-04-14 2010-04-14 プロカルシトニンのレベルを測定することによる原発性非感染症疾患に罹患している患者における抗生物質処置のためのリスク評価 Active JP5650718B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09157886.4 2009-04-14
EP09157886 2009-04-14
PCT/EP2010/002279 WO2010118855A1 (en) 2009-04-14 2010-04-14 Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin

Publications (3)

Publication Number Publication Date
JP2012523573A JP2012523573A (ja) 2012-10-04
JP2012523573A5 true JP2012523573A5 (https=) 2012-11-15
JP5650718B2 JP5650718B2 (ja) 2015-01-07

Family

ID=40886944

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012505086A Active JP5650718B2 (ja) 2009-04-14 2010-04-14 プロカルシトニンのレベルを測定することによる原発性非感染症疾患に罹患している患者における抗生物質処置のためのリスク評価

Country Status (15)

Country Link
US (3) US9046532B2 (https=)
EP (1) EP2419741B1 (https=)
JP (1) JP5650718B2 (https=)
CN (2) CN105334330A (https=)
CY (1) CY1122202T1 (https=)
DK (1) DK2419741T3 (https=)
ES (1) ES2751105T3 (https=)
HK (1) HK1221766A1 (https=)
HR (1) HRP20191862T1 (https=)
HU (1) HUE046182T2 (https=)
LT (1) LT2419741T (https=)
PL (1) PL2419741T3 (https=)
PT (1) PT2419741T (https=)
SI (1) SI2419741T1 (https=)
WO (1) WO2010118855A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2836841B1 (en) * 2012-04-12 2022-01-05 B.R.A.H.M.S GmbH Prognosis of adverse events in patients with suspected chronic heart failure
CN105528511A (zh) * 2014-10-25 2016-04-27 潘一琦 一种远程诊疗对比式问诊方法及其系统
CN107301319B (zh) * 2017-06-26 2021-02-26 济南市儿童医院 儿科临床及科研中抗菌药物使用危险评估系统
JP7444776B2 (ja) * 2017-12-20 2024-03-06 ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 併存症を有する患者におけるプロカルシトニンに基づく抗生物質療法のガイダンス
EP3502706A1 (en) * 2017-12-20 2019-06-26 B.R.A.H.M.S GmbH Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314804A (en) * 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
DE19600875C1 (de) * 1996-01-12 1997-06-26 Brahms Diagnostica Gmbh Diagnostisches Verfahren zur Bestimmung der Ätiologie entzündlicher Prozesse
ATE395364T1 (de) * 1999-12-22 2008-05-15 Dade Behring Marburg Gmbh Gegen procalcitonin gerichtete antikörper, ihre herstellung und verwendung
JP2005522669A (ja) * 2001-08-20 2005-07-28 バイオサイト インコーポレイテッド 卒中および脳損傷の診断マーカーおよびその使用方法
US20050148029A1 (en) * 2003-09-29 2005-07-07 Biosite, Inc. Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
DE102005034174A1 (de) * 2005-07-21 2007-02-08 B.R.A.H.M.S Ag Liquordiagnostisches in vitro Verfahren zur Diagnose von Demenz-Erkrankungen und neuroinflammatorischen Erkrankungen
FR2894675B1 (fr) * 2005-12-14 2008-06-27 Assist Publ Hopitaux De Paris Distinction des meningites bacteriennes et virales
DE102006046996A1 (de) * 2006-10-01 2008-04-03 Brahms Aktiengesellschaft Diagnose von Infektionen oder Entzündungserkrankungen der Atemwege und Lunge assoziiert mit Herzinsuffizienz
CN103123359B (zh) * 2007-08-03 2015-07-29 B.R.A.H.M.S有限公司 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用

Similar Documents

Publication Publication Date Title
Behr The diagnosis and treatment of idiopathic pulmonary fibrosis
Jeschke et al. Morbidity and survival probability in burn patients in modern burn care
Kalinke et al. The promises and challenges of early non‐small cell lung cancer detection: patient perceptions, low‐dose CT screening, bronchoscopy and biomarkers
Innes et al. Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost‐effectiveness
Corhay et al. Chronic bronchitis in COPD patients is associated with increased risk of exacerbations: a cross‐sectional multicentre study
Shi et al. Tumour biomarkers: association with heart failure outcomes
CN101790687A (zh) 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用
EP3482201A1 (en) Early diagnosis of infections
Dhawan et al. Predictors of Mortality for Nursing Home‐Acquired Pneumonia: A Systematic Review
Brussino et al. Inflammatory cytokines and VEGF measured in exhaled breath condensate are correlated with tumor mass in non-small cell lung cancer
JP2012523573A5 (https=)
Pan et al. Combination of IL-6, IL-10, and MCP-1 with traditional serum tumor markers in lung cancer diagnosis and prognosis
JP2023111913A (ja) pro-ADMに基づく抗生物質療法の指導
Seah et al. Interleukin-4 and its alternatively spliced variant (IL-4 δ 2) in patients with atopic asthma
Xu et al. Predictive value of combined LIPS and ANG‐2 level in critically ill patients with ARDS risk factors
Boeckmans et al. Liver stiffness as a cornerstone in heart disease risk assessment
Schiavetti et al. Long‐term renal function in unilateral non‐syndromic renal tumor survivors treated according to International Society of Pediatric Oncology protocols
Bernardes et al. Myocardial perfusion in rheumatoid arthritis patients: associations with traditional risk factors and novel biomarkers
CN105717146A (zh) 一种基于ct影像及生物标志物谱针对中国城市人口高危人群的肺癌风险预测试剂盒
Guervilly et al. A strategy based on galactomannan antigen detection and PCR for invasive pulmonary aspergillosis following influenza A (H1N1) pneumonia
Lin et al. Integrated bioinformatic analysis reveals TXNRD1 as a novel biomarker and potential therapeutic target in idiopathic pulmonary arterial hypertension
Carmona et al. Inflammation, myocardial dysfunction, and mortality in children with septic shock: an observational study
JP2017519008A5 (https=)
JPWO2019117269A1 (ja) 膵がんの検出を補助する方法
Wan et al. Postinfectious bronchiolitis obliterans in children